These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 22500174

  • 1. Nasopharyngeal carcinoma signaling pathway: an update on molecular biomarkers.
    Tulalamba W, Janvilisri T.
    Int J Cell Biol; 2012; 2012():594681. PubMed ID: 22500174
    [Abstract] [Full Text] [Related]

  • 2. Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.
    Tu C, Zeng Z, Qi P, Li X, Guo C, Xiong F, Xiang B, Zhou M, Liao Q, Yu J, Li Y, Li X, Li G, Xiong W.
    Carcinogenesis; 2018 Dec 31; 39(12):1517-1528. PubMed ID: 30102338
    [Abstract] [Full Text] [Related]

  • 3. Prognostic Value of Molecular Markers and Implication for Molecular Targeted Therapies in Nasopharyngeal Carcinoma: An Update in an Era of New Targeted Molecules Development.
    Liu MT, Chen MK, Huang CC, Huang CY.
    World J Oncol; 2015 Feb 31; 6(1):243-261. PubMed ID: 29147412
    [Abstract] [Full Text] [Related]

  • 4. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
    Wan XX, Yi H, Qu JQ, He QY, Xiao ZQ.
    Oncol Rep; 2015 Nov 31; 34(5):2585-601. PubMed ID: 26330189
    [Abstract] [Full Text] [Related]

  • 5. The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma.
    Lung ML, Cheung AK, Ko JM, Lung HL, Cheng Y, Dai W.
    Chin J Cancer; 2014 Nov 31; 33(11):556-68. PubMed ID: 25367335
    [Abstract] [Full Text] [Related]

  • 6. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
    Tu C, Zeng Z, Qi P, Li X, Yu Z, Guo C, Xiong F, Xiang B, Zhou M, Gong Z, Liao Q, Yu J, He Y, Zhang W, Li X, Li Y, Li G, Xiong W.
    J Virol; 2017 Sep 01; 91(17):. PubMed ID: 28637758
    [Abstract] [Full Text] [Related]

  • 7. MicroRNAs serving as potential biomarkers and therapeutic targets in nasopharyngeal carcinoma: A critical review.
    Lee KT, Tan JK, Lam AK, Gan SY.
    Crit Rev Oncol Hematol; 2016 Jul 01; 103():1-9. PubMed ID: 27179594
    [Abstract] [Full Text] [Related]

  • 8. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
    Zhang J, Jia L, Tsang CM, Tsao SW.
    Adv Exp Med Biol; 2017 Jul 01; 1018():75-90. PubMed ID: 29052133
    [Abstract] [Full Text] [Related]

  • 9. Radio-Susceptibility of Nasopharyngeal Carcinoma: Focus on Epstein- Barr Virus, MicroRNAs, Long Non-Coding RNAs and Circular RNAs.
    Lei F, Lei T, Huang Y, Yang M, Liao M, Huang W.
    Curr Mol Pharmacol; 2020 Jul 01; 13(3):192-205. PubMed ID: 31880267
    [Abstract] [Full Text] [Related]

  • 10. Current Status and Future Perspectives about Molecular Biomarkers of Nasopharyngeal Carcinoma.
    Siak PY, Khoo AS, Leong CO, Hoh BP, Cheah SC.
    Cancers (Basel); 2021 Jul 12; 13(14):. PubMed ID: 34298701
    [Abstract] [Full Text] [Related]

  • 11. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ, Tong S, Zhang G, Zong J, Chen Y, Jin DY, Chen MR, Pan J, Chen H.
    J Virol; 2016 Jul 15; 90(14):6475-88. PubMed ID: 27147748
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr Virus Mediated Signaling in Nasopharyngeal Carcinoma Carcinogenesis.
    Richardo T, Prattapong P, Ngernsombat C, Wisetyaningsih N, Iizasa H, Yoshiyama H, Janvilisri T.
    Cancers (Basel); 2020 Aug 28; 12(9):. PubMed ID: 32872147
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma.
    Zhu QY, Kong XW, Sun C, Xie SH, Hildesheim A, Cao SM, Zeng MS.
    mSphere; 2020 Dec 02; 5(6):. PubMed ID: 33268566
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma.
    Tan LP, Tan GW, Sivanesan VM, Goh SL, Ng XJ, Lim CS, Kim WR, Mohidin TBBM, Mohd Dali NS, Ong SH, Wong CY, Sawali H, Yap YY, Hassan F, Pua KC, Koay CE, Ng CC, Khoo AS, Malaysian Nasopharyngeal Carcinoma Study Group.
    Int J Cancer; 2020 Apr 15; 146(8):2336-2347. PubMed ID: 31469434
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Translational genomics of nasopharyngeal cancer.
    Tsang CM, Lui VWY, Bruce JP, Pugh TJ, Lo KW.
    Semin Cancer Biol; 2020 Apr 15; 61():84-100. PubMed ID: 31521748
    [Abstract] [Full Text] [Related]

  • 20. The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.
    Tsang CM, Tsao SW.
    Virol Sin; 2015 Apr 15; 30(2):107-21. PubMed ID: 25910483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.